AKTX
$1.43
Akari Therapeutics ADR
($.02)
(1.38%)
AKTX
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Mar 4
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when AKTX reports earnings?
Beat
Meet
Miss

Where is AKTX's stock price going from here?
Up
Flat
Down
Stock chart of AKTX
Analysts
Summary of analysts' recommendations for AKTX
Score
Grade
Pivots
Resistance
$1.54
$1.52
$1.47

$1.45

Support
$1.40
$1.38
$1.33
Tweet
Growth
Description
Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.